A detailed history of Carnegie Lake Advisors LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Carnegie Lake Advisors LLC holds 10,000 shares of VXRT stock, worth $6,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$6,000
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$0.58 - $0.99 $5,800 - $9,900
10,000 New
10,000 $8,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $75.9M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Carnegie Lake Advisors LLC Portfolio

Follow Carnegie Lake Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Lake Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Lake Advisors LLC with notifications on news.